BFM
HRMY icon

Boothbay Fund Management’s Harmony Biosciences HRMY Stock Holding History

Boothbay Fund Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,947
Closed -$318K – 1680
2024
Q3 		$318K Buy
+7,947
New +$279K 0.01% 1197
2022
Q3 		– Sell
-12,711
Closed -$620K – 2388
2022
Q2 		$620K Buy
+12,711
New +$572K 0.02% 1067
2021
Q4 		– Sell
-8,541
Closed -$327K – 2004
2021
Q3 		$327K Buy
+8,541
New +$275K 0.01% 1287

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boothbay Fund Management's HRMY Position: Q4 2024 in Review

Boothbay Fund Management sold out of Harmony Biosciences (HRMY) in Q4 2024, closing a stake of 7,947 shares — an estimated $318K sold.

Boothbay Fund Management first reported a position in HRMY in Q3 2021 and held it in 3 quarters. The position peaked at $620K in Q2 2022. 247 funds tracked by Wall St. Rank hold HRMY as of Q4 2024.

  • Boothbay Fund Management reported no remaining Harmony Biosciences position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 7,947 Harmony Biosciences shares in Q4 2024, an estimated $318K.
  • Boothbay Fund Management first reported a position in Harmony Biosciences in Q3 2021 and held it in 3 quarters.
  • Boothbay Fund Management's Harmony Biosciences position peaked at $620K in Q2 2022.
  • 247 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.